These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1806 related items for PubMed ID: 18852664
1. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM. Transplantation; 2008 Oct 15; 86(7):968-76. PubMed ID: 18852664 [Abstract] [Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
5. Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine. Görner M, Kordelas L, Thalheimer M, Luft T, Pfeiffer S, Ustaoglu F, Punzel M, Weber-Nordt R, Moos M, Goldschmidt H, Ho AD. Bone Marrow Transplant; 2002 Apr 15; 29(7):621-4. PubMed ID: 11979314 [Abstract] [Full Text] [Related]
7. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. Johansson JE, Brune M, Ekman T. Bone Marrow Transplant; 2001 Oct 15; 28(8):737-42. PubMed ID: 11781624 [Abstract] [Full Text] [Related]
8. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning. Grigg AP, Gibson J, Bardy PG, Reynolds J, Shuttleworth P, Koelmeyer RL, Szer J, Roberts AW, To LB, Kennedy G, Bradstock KF. Biol Blood Marrow Transplant; 2007 May 15; 13(5):560-7. PubMed ID: 17448915 [Abstract] [Full Text] [Related]
12. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality. Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W. Ann Hematol; 2005 May 15; 84(5):331-8. PubMed ID: 15726363 [Abstract] [Full Text] [Related]
13. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L. Blood Cells Mol Dis; 2008 May 15; 40(1):13-9. PubMed ID: 17869547 [Abstract] [Full Text] [Related]
14. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Uzunel M, Remberger M, Sairafi D, Hassan Z, Mattsson J, Omazic B, Barkholt L, Ringdén O. Transplantation; 2006 Oct 15; 82(7):913-9. PubMed ID: 17038906 [Abstract] [Full Text] [Related]
16. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Pérez-Simón JA, Díez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD, de León A, Valcárcel D, Carreras E, del Cañizo MC, López-Fidalgo J, Sierra J, San Miguel JF. Br J Haematol; 2005 Aug 15; 130(3):394-403. PubMed ID: 16042689 [Abstract] [Full Text] [Related]
17. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM, Gorechlad J, Larsen CP, Waller EK. Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205 [Abstract] [Full Text] [Related]
18. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M. Biol Blood Marrow Transplant; 1999 Dec 15; 5(3):133-43. PubMed ID: 10392959 [Abstract] [Full Text] [Related]
19. GVHD after chemotherapy conditioning in allogeneic transplanted mice. Sadeghi B, Aghdami N, Hassan Z, Forouzanfar M, Rozell B, Abedi-Valugerdi M, Hassan M. Bone Marrow Transplant; 2008 Dec 15; 42(12):807-18. PubMed ID: 18820712 [Abstract] [Full Text] [Related]
20. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J. J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]